Post-Treatment Viral Evolution Assessment Using Ultra-Deep Pyrosequencing in Samples from Patients with Hepatitis C Virus Infection: The EXTEND Study

被引：0
|
作者：
Dierynck, Inge [1 ]
Thys, Kim [1 ]
Bartels, Doug J. [2 ]
Ghys, Anne [1 ]
Van Rossem, Elizabeth [1 ]
Zhang, Eileen Z. [2 ]
Davis, Andrew [2 ]
Friedman, Mark I. [2 ]
Kieffer, Tara L. [2 ]
Aerssens, Jeroen [1 ]
De Meyer, Sandra [1 ]
Sullivan, James C. [2 ]
机构：
[1] Janssen Infect Dis BVBA, Beerse, Belgium
[2] Vertex Pharmaceut Inc, Cambridge, MA USA
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1510
引用
收藏
页码：939A / 940A
页数：2
相关论文
共 35 条
  • [21] A GENOTYPE-SPECIFIC BASELINE SCORE TO PREDICT POST-TREATMENT RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-POSITIVE PATIENTS WITH HEPATITIS B VIRUS GENOTYPE B OR C INFECTION
    Chan, H. L. -Y.
    Messinger, D.
    Papatheodoridis, G. V.
    Cornberg, M.
    Xie, Q.
    Piratvisuth, T.
    Ren, H.
    Kennedy, P.
    Thompson, A. J.
    Caputo, A.
    Bakalos, G.
    Pavlovic, V.
    Lampertico, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S589 - S590
  • [22] Ultra-deep sequencing analysis of resistance-associated variants during retreatment with simeprevir-based triple therapy after failure of telaprevir-based triple therapy in patients with genotype 1 hepatitis C virus infection
    Morishita, Naoki
    Hiramatsu, Naoki
    Oze, Tsugiko
    Urabe, Ayako
    Tahata, Yuki
    Yamada, Ryoko
    Yakushijin, Takayuki
    Hosui, Atsushi
    Iio, Sadaharu
    Yamada, Akira
    Hagiwara, Hideki
    Mita, Eiji
    Yamada, Yukinori
    Ito, Toshifumi
    Inada, Masami
    Katayama, Kazuhiro
    Yabuuchi, Iwao
    Imai, Yasuharu
    Hikita, Hayato
    Sakamori, Ryotaro
    Yoshida, Yuichi
    Tatsumi, Tomohide
    Hayashi, Norio
    Takehara, Tetsuo
    HEPATOLOGY RESEARCH, 2017, 47 (08) : 773 - 782
  • [23] Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients.: Pre- and post-renal transplantation assessment
    Campistol, JM
    Esforzado, N
    Martínez, J
    Roselló, L
    Veciana, L
    Modol, J
    Casellas, J
    Pons, M
    de las Cuevas, X
    Piera, J
    Oliva, JA
    Costa, J
    Barrera, JM
    Bruguera, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (11) : 2704 - 2709
  • [24] Efficacy and safety of Ombitasvir/paritaprevir/ritonavir and dasabuvir in non-cirrhotic Asian patients with genotype 1b chronic hepatitis C virus infection: ONYX-I post-treatment week 24 results
    Wei, L.
    Hou, J.
    Luo, Y.
    Heo, J.
    Chu, C. -J.
    Duan, Z.
    Cho, M.
    Cheng, J.
    Li, J.
    Jia, J.
    Lu, W.
    Fredrick, L. M.
    Pilot-Matias, T.
    Mobashery, N.
    Chuang, W. -L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S532 - S532
  • [25] Twelve week post-treatment undetectable hepatitis C virus (HCV)-RNA by PCR assay predicts a sustained virological response to anti-HCV therapy independently from immunological status of the infected patients
    Donato, Maria Francesca
    Bastiampillai, Anan Judina
    Manini, Matteo
    Monica, Sara
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (04) : 974 - 975
  • [26] Use of the 6 million viral load cut-off to guide treatment duration with ledipasvir/sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection: results from the German Hepatitis C-Registry (DHC-R)
    Vermehren, J.
    Athmann, C.
    Guenther, R.
    Schott, E.
    Pathil, A.
    Boeker, K. H.
    Cornberg, M.
    Niederau, C.
    Simon, K. -G.
    Maasoumy, B.
    Sarrazin, C.
    Wedemeyer, H.
    Buggisch, P.
    C-Registry, G. H.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S519 - S520
  • [27] Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center
    Gupta, Varun
    Kumar, Ashish
    Sharma, Praveen
    Bansal, Naresh
    Singla, Vikas
    Arora, Anil
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2015, 5 (02) : 134 - 141
  • [28] SAFETY OF DIRECT-ACTING ANTIVIRALS-BASED THERAPY FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND CIRRHOSIS: RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT STUDY
    Maan, R.
    van Tilborg, M.
    Deterding, K.
    Ramji, A.
    van der Meer, A. J.
    Wong, F.
    Fung, S.
    Sherman, M.
    Manns, M. P.
    Cornberg, M.
    Wedemeyer, H.
    Janssen, H. L.
    de Knegt, R. J.
    Feld, J. J.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S812 - S813
  • [29] Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection
    Howe, Anita Y. M.
    Black, Stuart
    Curry, Stephanie
    Ludmerer, Steven W.
    Liu, Rong
    Barnard, Richard J. O.
    Newhard, William
    Hwang, Peggy M. T.
    Nickle, David
    Gilbert, Christopher
    Caro, Luzelena
    DiNubile, Mark J.
    Mobashery, Niloufar
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (12) : 1657 - 1665
  • [30] Achievement of Sustained Viral Response after Switching Treatment from Pegylated Interferon α-2b to α-2a and Ribavirin in Patients with Recurrence of Hepatitis C Virus Genotype 1 Infection after Liver Transplantation: A Case Report
    Kawaoka, Tomokazu
    Hiraga, Nobuhiko
    Takahashi, Shoichi
    Takaki, Shintaro
    Tsuge, Masataka
    Nagaoki, Yuko
    Hashimoto, Yoshimasa
    Katamura, Yoshio
    Miki, Daiki
    Hiramatsu, Akira
    Waki, Koji
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Tashiro, Hirotaka
    Ohdan, Hideki
    Chayama, Kazuaki
    INTERVIROLOGY, 2012, 55 (04) : 306 - 310
1234